Hexima (ASX:HXL) Common Stock : A$82.88 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Hexima Common Stock?

Hexima's quarterly common stock stayed the same from Dec. 2022 (A$82.88 Mil) to Jun. 2023 (A$82.88 Mil) and stayed the same from Jun. 2023 (A$82.88 Mil) to Dec. 2023 (A$82.88 Mil).

Hexima's annual common stock declined from Jun. 2022 (A$82.89 Mil) to Jun. 2023 (A$82.88 Mil) but then stayed the same from Jun. 2023 (A$82.88 Mil) to Jun. 2024 (A$82.88 Mil).

Hexima Common Stock Historical Data

The historical data trend for Hexima's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hexima Common Stock Chart

Hexima Annual Data

Trend

Jun08

Jun09

Jun10

Jun20

Jun21

Jun22

Jun23

Jun24

Common Stock

Get a 7-Day Free Trial

72.05

71.91

82.89

82.88

Hexima Semi-Annual Data
	Dec06	Dec07	Jun08	Dec08	Jun09	Dec09	Jun10	Dec10	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Common Stock	Get a 7-Day Free Trial											82.89	82.88	82.88	82.88	82.88

Hexima Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Hexima Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Hexima Ltd (ASX:HXL) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

N/A

Address

C/- Acclime, 62 Lygon Street, Level 3, Carlton, VIC, AUS, 3053

Website

https://www.hexima.com.au

Hexima Ltd is a biotechnology company. The principal activity of the Group during the financial year was the exploration of transactions with third parties which could enable the potential value of the Company's assets, including its intellectual property, to be realized.